ASO Visual Abstract: Adjuvant Gemcitabine Versus Neoadjuvant/Adjuvant FOLFIRINOX in Resectable Pancreatic Cancer-The Randomized Multicenter Phase II NEPAFOX Trial

Ann Surg Oncol. 2024 Apr 4. doi: 10.1245/s10434-024-15145-8. Online ahead of print.
No abstract available